PREVENTIVE EFFECTIVENESS OF PREGABALIN IN CHRONIC NEUROPATHIC PAIN SYNDROME AFTER MASTECTOMY DUE TO CANCER

Among the population undergoing a mastectomy due to breast cancer, the incidence of chronic neuropathic pain syndrome (CNPS) is between 20 and 50%. This pathology increases the morbidity, delaying not only the rehabilitation process but also the return to daily activities with an impact on life quality. Given its difficult management, it is important to seek preventive strategies and interventions. Pregabalin is a therapeutic option because of its antineuropathic mechanism, of which its preventive efficacy in this syndrome is not clear.